News

Findings, from a new clinical trial, indicate that targeted forms of radiotherapy can effectively treat bladder cancer which has spread to the lymph nodes of the pelvis.

Boston researchers have developed a new way to generate groups of intestinal cells that can be used to make disease models in the lab to test treatments for diseases affecting the gastrointestinal system.

The nucleic acids of DNA encode genetic information, while the amino acids of proteins contain the code to turn that information into structures and functions. Together, they provide the two fundamental codes underlying all of life.

Engineers from Duke University and the Institut de Physique de Nice in France have developed a new method to identify objects using microwaves that improves accuracy while reducing the associated computing time and power requirements.

A study exploring the key molecular processes in mesothelioma, identified two drugs that, used in combination, could be effective against the most aggressive type of this cancer.

Researchers have discovered patients whose prostate tumors carry only one copy of PPP2R2A do not survive as long as those who have two copies of the gene. They also showed that in cells deficient in PPP2R2A, reconstitution of the PP2A protein (encoded by the gene) kills prostate cancer cells – reactivating PP2A in affected cells slow the advance of prostate cancer in an animal model.

Tea lovers, it's time to rejoice. A new research study published in the European Journal of Preventive Cardiology suggests that drinking tea at least three times per week is associated with a longer and healthier life.

According to a new study, an existing drug could be used to improve the womb for pregnancy in those who have had recurrent miscarriages.

A novel nanoparticle vaccine that combines two major influenza proteins is effective in providing broad, long-lasting protection against influenza virus in mice, showing promise as a universal flu vaccine, according to a study by the Institute for Biomedical Sciences at Georgia State University.

A new Penn Medicine study puts researchers within closer reach of vaccines that can protect infants against infections by overcoming a mother’s antibodies, which are known to shut down immune defenses initiated by conventional vaccines.